Building India's First Integrated Diagnostic Ecosystem

Genetic diseases affect millions of Indians, yet traditional diagnostic approaches often fall short in providing clear answers. The Metropolis Centre of Genomics represents a groundbreaking advancement in addressing these challenges through India's first integrated diagnostic ecosystem.

This pioneering genomic testing laboratory in India addresses a critical gap in Indian healthcare by creating a comprehensive platform that understands our unique genetic makeup. Unlike Western populations, Indian genetics differ significantly from Caucasian datasets used in most global studies. This genetic testing lab has developed an extensive database from thousands of Indian patients, creating a reference set that drives unprecedented accuracy in genetic analysis.

Role of Genomics in Modern Disease Management

Genomics helps doctors understand diseases at their root level—our genes. By studying DNA, healthcare providers not only can detect diseases but also predict health risks, choose the most effective treatments, and plan long-term care. For instance, advanced tests like whole-exome sequencing can identify genetic causes of unexplained developmental delays in children, offering families answers after years of uncertainty.

This is why genetic testing is becoming an important tool for early prevention, treatment planning, and informed family health decisions.

The comprehensive testing portfolio includes:

• Over 220 validated genetic tests are currently available, with plans to expand to 500+ assays within the next 2–3 years.
• Comprehensive genomic coverage across targeted gene panels.
• Testing areas include hereditary cancer syndromes, cardiovascular genetic conditions, neurological disorders, rare disease diagnostics, and pharmacogenomics.

Role of Genomics in Modern Disease Management

Significantly, the Centre of Genomics features a comprehensive in-house technology stack that ensures complete molecular profiling for patients. This integrated setup blends advanced sequencing technologies and analytical capabilities to support accurate, end-to-end genetic testing across diverse clinical needs.

At the core of this capability are next-generation sequencing (NGS) technologies designed to support both targeted and large-scale genomic analysis. It includes:

• Ion GeneStudio™ S5 Plus System: Enables flexible and efficient sequencing for focused genetic investigations, supporting a wide spectrum of inherited and acquired conditions.
• Ion Torrent Genexus System: A fully automated, specimen-to-report sequencing technology that streamlines workflows, reduces manual intervention, and accelerates turnaround times.
• NovaSeq™ X Platform: Supports high-intensity genomics through large-volume, high-throughput sequencing, delivering exceptional depth, scale, and data quality.

In-house Genomic Database of Indian Patients

The Centre of Genomics maintains an extensive in-house genomic database built from thousands of Indian patients. This invaluable resource enables superior result interpretation by accounting for genetic variations specific to Indian populations—variations often absent from Caucasian-dominated global databases.